|
|
|
Insider
Information: |
Reed Elizabeth E |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
77,308 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$521,687 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
77,308 |
|
|
Total
Value |
$521,687 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
12.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Anadys Pharmaceuticals Inc |
ANDS |
Senior Director, Legal... |
2006-04-10 |
1,038 |
2006-01-09 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
|
2024-02-01 |
76,270 |
2017-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ANDS |
Anadys Pharmaceuticals In... |
officerTitle |
|
2006-01-09 |
4 |
AS |
$10.00 |
$15,004 |
D/D |
(1,500) |
0 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
officerTitle |
|
2006-01-09 |
4 |
OE |
$2.95 |
$4,425 |
D/D |
1,500 |
1,500 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Senior Director, Legal Affairs |
|
2006-02-13 |
4 |
AS |
$10.81 |
$16,260 |
D/D |
(1,500) |
0 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Senior Director, Legal Affairs |
|
2006-02-13 |
4 |
OE |
$2.95 |
$4,425 |
D/D |
1,500 |
1,500 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Senior Director, Legal Affairs |
|
2006-04-10 |
4 |
AS |
$13.50 |
$20,507 |
D/D |
(1,500) |
1,038 |
|
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Senior Director, Legal Affairs |
|
2006-04-10 |
4 |
OE |
$2.95 |
$4,425 |
D/D |
1,500 |
2,538 |
|
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2017-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2018-01-05 |
4 |
S |
$24.04 |
$22,646 |
D/D |
(942) |
9,058 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,769 |
10,827 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
17,827 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2018-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
22,827 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2018-11-14 |
4 |
AS |
$23.62 |
$59,330 |
D/D |
(2,500) |
20,327 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2018-11-15 |
4 |
AS |
$24.29 |
$60,816 |
D/D |
(2,500) |
17,827 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2019-01-08 |
4 |
AS |
$24.09 |
$18,068 |
D/D |
(750) |
17,077 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2019-01-09 |
4 |
AS |
$23.82 |
$17,865 |
D/D |
(750) |
16,327 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2019-02-11 |
4 |
AS |
$21.38 |
$18,921 |
D/D |
(885) |
15,442 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2019-02-12 |
4 |
AS |
$21.50 |
$19,006 |
D/D |
(884) |
14,558 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
20,558 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2019-05-14 |
4 |
AS |
$17.75 |
$9,319 |
D/D |
(525) |
20,033 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2019-05-15 |
4 |
AS |
$17.71 |
$9,298 |
D/D |
(525) |
19,508 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2020-01-07 |
4 |
AS |
$13.94 |
$10,455 |
D/D |
(750) |
18,758 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2020-01-08 |
4 |
AS |
$15.14 |
$11,355 |
D/D |
(750) |
18,008 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
27,008 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
30,508 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
|
2020-03-10 |
4 |
AS |
$15.02 |
$52,570 |
D/D |
(3,500) |
27,008 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|